Summary Immunotherapy was proven to be effective as first-line treatment for a subgroup of patients with gastroesophageal tumors and is already established the standard care. However, chemotherapy remains backbone in both advanced resectable stages. Dual checkpoint inhibition produces synergistic activation immune cells enhanced antitumor activity, could thus represent an alternative chemothera...